Amica Retiree Medical Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Amica Retiree Medical Trust’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$148K	Hold	264	–	–	0.2%	90
2025 Q2	$139K	Hold	264	–	–	0.2%	88
2025 Q1	$167K	Sell	264 -63	-19%	-$43.3K	0.26%	80
2024 Q4	$233K	Sell	327 -28	-8%	-$23.5K	0.22%	81
2024 Q3	$373K	Buy	+355	New	+$395K	0.31%	77
2023 Q3	$310K	Hold	377	–	–	0.36%	80
2023 Q2	$271K	Sell	377 -24	-6%	-$18.5K	0.3%	84
2023 Q1	$330K	Hold	401	–	–	0.35%	85
2022 Q4	$289K	Sell	401 -207	-34%	-$153K	0.37%	83
2022 Q3	$419K	Buy	608 +63	+12%	+$39.7K	0.52%	67
2022 Q2	$322K	Sell	545 -94	-15%	-$61.1K	0.37%	84
2022 Q1	$446K	Hold	639	–	–	0.42%	79
2021 Q4	$404K	Buy	639 +135	+27%	+$83K	0.34%	86
2021 Q3	$305K	Sell	504 -223	-31%	-$138K	0.28%	92
2021 Q2	$406K	Hold	727	–	–	0.26%	94
2021 Q1	$344K	Hold	727	–	–	0.23%	103
2020 Q4	$351K	Hold	727	–	–	0.25%	102
2020 Q3	$407K	Hold	727	–	–	0.32%	94
2020 Q2	$453K	Hold	727	–	–	0.36%	88
2020 Q1	$355K	Hold	727	–	–	0.32%	98
2019 Q4	$273K	Hold	727	–	–	0.21%	137
2019 Q3	$202K	Buy	727 +373	+105%	+$110K	0.16%	201
2019 Q2	$111K	Buy	+354	New	+$118K	0.09%	246

Other funds holding REGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amica Retiree Medical Trust's REGN Position: Q3 2025 in Review

Amica Retiree Medical Trust held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2025 at 264 shares worth $148K. The position accounts for 0.2% of the portfolio, ranked #90.

Amica Retiree Medical Trust first reported a position in REGN in Q2 2019 and has held it in 23 quarters since. The position peaked at $453K in Q2 2020. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

Amica Retiree Medical Trust held 264 shares of Regeneron Pharmaceuticals worth $148K as of Q3 2025.
Amica Retiree Medical Trust left its Regeneron Pharmaceuticals share count unchanged in Q3 2025.
Regeneron Pharmaceuticals made up 0.2% of Amica Retiree Medical Trust's portfolio in Q3 2025, its #90 holding.
Amica Retiree Medical Trust first reported a position in Regeneron Pharmaceuticals in Q2 2019 and has held it in 23 quarters since.
Amica Retiree Medical Trust's Regeneron Pharmaceuticals position peaked at $453K in Q2 2020.
1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Amica Retiree Medical Trust's 13F filing for Q3 2025, filed 7 Nov 2025.